Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Third- and fourth-generation implantable cardioverter defibrillators: current status and future development.

S Saksena1, M L Diaz, S Varanasi

  • 1Pacemaker & Arrhythmia Service, Eastern Heart Institute, Passaic, New Jersey, USA.

Journal of Interventional Cardiology
|September 5, 1994
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short- and long-term prognostic performance of exercise ECG and myocardial perfusion SPECT.

Clinical physiology and functional imaging·2024
Same author

Fungal Planet description sheets: 1436-1477.

Persoonia·2024
Same author

Predation risk drives long-term shifts in migratory behaviour and demography in a large herbivore population.

The Journal of animal ecology·2023
Same author

Integrating EM and Patch-seq data: Synaptic connectivity and target specificity of predicted Sst transcriptomic types.

bioRxiv : the preprint server for biology·2023
Same author

Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Ventricular longitudinal shortening is an independent predictor of death in heart failure patients with reduced ejection fraction.

Scientific reports·2021

Implantable cardioverter defibrillators (ICDs) are crucial for preventing sudden cardiac death and treating ventricular arrhythmias. Ongoing research focuses on improving ICD shock efficacy, lead systems, and exploring new prevention strategies for tachycardia.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Implantable cardioverter defibrillators (ICDs) are the primary treatment for patients at risk of sudden cardiac death or life-threatening ventricular arrhythmias.
  • Current ICDs offer tachycardia reversion, pacing, programmable shock therapy, and event memory, with debated applications for antitachycardia pacing modes.

Purpose of the Study:

  • To review the current state and future directions of implantable cardioverter defibrillator (ICD) therapy.
  • To discuss advancements in ICD technology, including device size reduction and improved lead systems.
  • To explore emerging clinical applications and research into novel tachycardia prevention strategies.

Main Methods:

  • Review of current implantable cardioverter defibrillator (ICD) technology and clinical applications.

Related Experiment Videos

  • Discussion of advancements in device engineering, including lead configurations and implant techniques.
  • Examination of ongoing clinical trials and research into novel antiarrhythmic and tachycardia prevention methods.

    • Main Results:

    • Fourth-generation ICD systems have achieved significant size reduction and high implantation success rates with endocardial leads.
    • The efficacy of antitachycardia pacing modes remains a subject of ongoing investigation and clinical trials.
    • Development of more effective defibrillation shock modes and lead systems is redefining sudden death prevention.

    Conclusions:

    • Implantable cardioverter defibrillator (ICD) therapy is continuously evolving with advancements in device technology and lead systems.
    • Future directions include expanded primary prevention applications and adjunctive antiarrhythmic drug therapy.
    • Research into the underlying mechanisms of tachyarrhythmias is driving innovation in tachycardia prevention strategies.